Eight brokerages currently cover AngloGold Ashanti, collectively assigning a consensus recommendation of “Moderate Buy.” Six analysts rate the stock as a buy, one as a hold and one as a sell. Recent independent research reports include Zacks Research’s downgrade from strong-buy to hold and Scotiabank’s upgrade to a sector outperform rating, underscoring mixed but overall positive sentiment. Wall Street Zen has also elevated its view from hold to buy, while Weiss Ratings moved from a hold (c+) to a buy (b-) stance, and JPMorgan Chase upgraded its rating to overweight.

In its latest quarter, AngloGold Ashanti reported earnings per share of 1.32, narrowly missing consensus estimates by 0.02. Revenue came in at 2.42 billion dollars versus analyst expectations of 2.53 billion, delivering a net margin of 26.25% and a return on equity of 24.01%. The company’s balance sheet remains healthy, with a quick ratio of 1.98, a current ratio of 2.58 and a debt-to-equity ratio of 0.21, reflecting conservative leverage in an industry cyclically tied to commodity prices.

AngloGold Ashanti recently declared a quarterly dividend of 0.91 per share, translating to an annualized payout of 3.64 and a yield of 3.7%, with a dividend-payout ratio of 80.18%. Institutional investors hold 36.09% of outstanding shares. Notable changes in the first two quarters include Empowered Funds LLC establishing a new position valued at about 321 000 dollars; Rhumbline Advisers boosting its stake by 194.3% to 31,619 shares worth roughly 1.17 million; and Counterpoint Mutual Funds LLC initiating a 1.87 million‐dollar position, signaling growing confidence among large-scale holders.